{
    "Trade/Device Name(s)": [
        "VivaChek Link Plus Blood Glucose Monitoring System",
        "VivaChek Link Plus Blood Glucose Meter",
        "VivaChek Ino Blood Glucose Test Strips"
    ],
    "Submitter Information": "VivaChek Biotech (Hangzhou) Co., Ltd.",
    "510(k) Number": "K233058",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173140"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "December 22, 2023",
    "Summary Letter Received Date": "September 25, 2023",
    "Submission Date": "September 20, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "VivaChek Link Plus Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips"
    ],
    "Document Summary": "FDA 510(k) summary for VivaChek Link Plus Blood Glucose Monitoring System for quantitative measurement of glucose in fresh capillary whole blood using amperometric detection.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the fingertips for persons with diabetes to monitor effectiveness of diabetes control; for self-testing outside the body (in vitro diagnostic use), not for neonatal use or diagnosis/screening of diabetes, and not to be shared between users.",
    "fda_folder": "Clinical Chemistry"
}